Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Antibiotics
- Balanced Salt Solutions
- Cell Dissociation Reagents
- Cell Freezing Media
- Cell Health Assays
- Cell Identification Service
- Cell Lines
- Complete Growth Media
- Cytokines
- Exosome Isolation Kits
- Growth Supplements
- Induced Differentiation Media
- Liquid Basal Media
- Other Reagents
- Powder Basal Media
- Primary Cell Isolation and Culture Kit
- Primary Cells
- Removal Media
- Removal Reagents
- Serum
- Serum-Free Media
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Kyrgyzstan
- Luxembourg
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 32,895 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Ursodeoxycholic Acid Platinum(IV) Conjugates as Antiproliferative and Antimetastatic Agents: Remodel the Tumor Microenvironment through Suppressing JAK2/STAT3 Signaling (2024-09-18)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6.8Products Cited: HL-7702 [L-02; LO2] Cells Line -
Discovery of a Covalent Inhibitor of Pro-Caspase-1 Zymogen Blocking NLRP3 Inflammasome Activation and Pyroptosis (2024-08-19)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6.8Products Cited: -
Fully Synthetic TF-Based Self-Adjuvanting Vaccine Simultaneously Triggers iNKT Cells and Mincle and Protects Mice against Tumor Development (2024-09-20)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6.8 -
Novel PD-L1/VISTA Dual Inhibitor as Potential Immunotherapy Agents (2024-12-28)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6.8Products Cited: -
Advancing Cancer Immunotherapy through Engineering New PD-L1 Degraders: A Comprehensive Study from Small Molecules to PD-L1-Specific Peptide–Drug Conjugates (2024-10-18)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6.8Products Cited: -
Polypharmacological Drug Design Guided by Integrating Phenotypic and Restricted Fragment Docking Strategies (2024-09-19)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6.8Products Cited: -
Discovery of Orally Active Phenylquinoline-Based Soluble Epoxide Hydrolase Inhibitors with Anti-Inflammatory and Analgesic Activity (2024-10-03)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6.8Products Cited: Penicillin-Streptomycin Solution, 100 ×, Fetal Bovine Serum -
68Ga/177Lu-Labeled Theranostic Pair for Targeting Fibroblast Activation Protein with Improved Tumor Uptake and Retention (2024-09-25)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6.8Products Cited: -
Discovery of Thiazole Carboxamides as Novel Vanin-1 Inhibitors for Inflammatory Bowel Disease Treatment (2024-11-08)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6.8Products Cited: McCoy's 5A Medium -
Structure-Guided Design of Affinity/Covalent-Bond Dual-Driven Inhibitors Targeting the AMP Site of FBPase (2024-11-09)
Journal: JOURNAL OF MEDICINAL CHEMISTRY (2024) IF: 6.8Products Cited: RPMI-1640 Medium
